The role of the ADVanced Organ Support (ADVOS) system in critically ill patients with multiple organ failure.

. ADVOS is associated with significant improvements in hemodynamic and biochemical parameters, a trend toward improved survival in multi-organ failure, and is well-tolerated. Larger randomized trials are now necessary to further validate these encouraging results.